New whooping cough vaccine shows promise in toddler trial
NCT ID NCT07213089
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tested a new booster vaccine (DTaPgen) in 290 healthy toddlers aged 15 to 36 months to see if it works as well as a current vaccine against whooping cough. The new vaccine uses a safer, genetically detoxified pertussis toxin. The goal was to compare immune response and safety after a single booster dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERTUSSIS WHOOPING COUGH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kamphaengphet Hospital
Kamphaeng Phet, Changwat Kamphaeng Phet, 62000, Thailand
-
Phaholpolpayuhasena Hospital
Kanchanaburi, Kanchanaburi, 71000, Thailand
-
Vaccine Trial Centre (VTC), Faculty of Tropical Medicine, Mahidol University
Bangkok, Bangkok, 10400, Thailand
Conditions
Explore the condition pages connected to this study.